Results 71 to 80 of about 3,554 (229)
Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations [PDF]
Objective: The studies that have extensively evaluated the relation between adipokines and metabolic parameters in acromegaly treatment are quite discordant. We aimed to evaluate and correlate a set of selected adipokines, known to have a metabolic role,
Amato, M. +3 more
core +1 more source
The development of drug delivery systems is revolutionizing therapeutic progress by ensuring precise targeting and optimal drug concentrations. Nanocarriers, with their customizable properties and controlled release, overcome biological barriers to improve treatment outcomes. This study explores the potential of integrating artificial intelligence with
Minhye Kim +4 more
wiley +1 more source
Trigeminal (TG), dorsal root (DRG), and nodose/jugular (NG/JG) ganglia each possess specialized and distinct functions. We used RNA sequencing of two-cycle sorted Pirt-positive neurons to identify genes exclusively expressing in L3–L5 DRG, T10-L1 DRG, NG/
Anahit H. Hovhannisyan +13 more
doaj +1 more source
Pregnancy and acromegaly [PDF]
Introduction: Acromegaly is a rare disorder in which, due to the high incidence of secondary hypogonadism, pregnancies are relatively rare. However, some women with acromegaly do get pregnant, which brings along questions about medication, complications ...
Lely, A-J. (Aart-Jan) van der +2 more
core +1 more source
Pegvisomant in acromegaly: an update [PDF]
In 2007, we published an opinion document to review the role of pegvisomant (PEG) in the treatment of acromegaly. Since then, new evidence emerged on the biochemical and clinical effects of PEG and on its long-term efficacy and safety.We here reviewed the emerging aspects of the use of PEG in clinical practice in the light of the most recent literature.
Giustina, A +13 more
openaire +7 more sources
Acromegaly management in the Nordic countries: A Delphi consensus survey
Abstract Objective Acromegaly is associated with increased morbidity and mortality if left untreated. The therapeutic options include surgery, medical treatment, and radiotherapy. Several guidelines and recommendations on treatment algorithms and follow‐up exist. However, not all recommendations are strictly evidence‐based. To evaluate consensus on the
Mai C. Arlien‐Søborg +47 more
wiley +1 more source
Background The approach to acromegalic patients with persistent acromegaly after surgery and inadequate response to first-generation somatostatin receptor ligands (SRLs) should be strictly tailored.
A. Ciresi +3 more
doaj +1 more source
Treatment adherence to pegvisomant (somavert®) in Spain: PEGASO study [PDF]
This is a pre-copyedited, author-produced version of an article accepted for publication in Endocrine Reviews following peer review.
Aller, J. +7 more
core
Improving quality of life in patients with pituitary tumours [PDF]
Evaluation of health-related quality of life (QoL) in people with pituitary tumours has received much attention over the last 10-15 years. Most of them show impaired QoL, but little is known about how to prevent impairment or how to improve QoL.
Crespo, Iris +5 more
core +1 more source
Abstract Aims Atrial fibrillation (AF) is the most common arrhythmia. Heart failure (HF) is a disease caused by heart dysfunction. The prevalence of AF and HF were progressively increasing over time. The co‐existence of AF and HF presents a significant therapeutic challenge.
Zhijun Zhang +9 more
wiley +1 more source

